1 / 7

The Pharmaceutical Sector in Ireland

The Pharmaceutical Sector in Ireland. SSDC Chemical Industry Plenary Meeting 9 th April 2013 Eurofound Dublin. Pharma Sector in Ireland. One of the premier global locations for pharmaceutical and chemical product manufacture

kumiko
Télécharger la présentation

The Pharmaceutical Sector in Ireland

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Pharmaceutical Sector in Ireland SSDC Chemical Industry Plenary Meeting 9th April 2013 Eurofound Dublin

  2. Pharma Sector in Ireland • One of the premier global locations for pharmaceutical and chemical product manufacture • Nine of top ten global pharma companies have a facility in Ireland • Exports of €55.1bn* = 50% of total value of Irish exports • Contribution of €1bn in corporation tax to the state • Sector employs 50,000 people directly and indirectly • Ireland is the second largest development and manufacturing location in the world for biopharmaceuticals • Largest net exporter of medicines in the world * CSO - 2011

  3. Challenges • Patent expiry – expected loss of $29bn in 2013* • Global over-capacity – 300,000 jobs cut since 2000* • Significant R&D costs – global R&D funding by large pharma to drop by 5.7% in 2012** • Product failure at late stage clinical trials • Declining pipelines • Downward pressure on healthcare costs due to budget pressures • Cost optimisation *Deloitte 2013 **Forbes 2011

  4. Opportunities • Talent – Highly skilled Irish workforce critical to the success of the sector. Global functions based out of Ireland increasing year on year • Taxation – 12.5% corporation tax rate in addition to 25% R&D tax credit • Compliance – Global quality standards falling while remaining very high in Ireland • OPEX – Irish sites accruing huge benefits from optimisation of OPEX best practice • D&M – Development plus Manufacturing model

  5. Workforce • Direct employment has grown from 5200 in 1988 to 24,000 in 2012 (additional 24,500 employed providing services) • 50% of employees have a university qualification • Exemplary compliance record – no warning letters have been issued to any Irish facility in last 10 years • Proven track record of manufacturing excellence • Strong local management (with global functions) • Flexible and adaptable workforce

  6. Broader environment • Irish economy has stabilised with GDP growth of 0.9% in 2012 • 85% of austerity has been delivered • Substantial improvement in unit labour costs • Private sector protocol renewed to end 2013 • 39% of firms planning increase to basic pay in 2013* However: • Pensions – 90% of DB plans in deficit • Health Insurance costs increasing year on year *IBEC Study Q4 2012

  7. The future is now • Focus is to sustain and create jobs • Talent development of a flexible workforce willing to embrace and facilitate change–key to delivering economic recovery and growth • Highly efficient, cost – effective manufacturing employing fully optimised operational excellence • Irish site - Site of choice for all new entities to market • Strong collaboration between industry partners • Industry working in close collaboration with government and academia

More Related